UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases. Read More
Even as a dispute rages by the day with letter-bombs being dropped by the warring promoters, IndiGo co-promoter Rahul Bhatia is unlikely to budge from his position and agree to dilute airline's control structure that gives him right to nominate Chair ...
Manpasand Beverages scrips hit lower circuit on the Bombay stock exchange over MD and CFO's arrest facing allegations of Goods and Services Tax (GST) fraud. ...